Cdk5 phosphorylates PLD2 to mediate EGF-dependent insulin secretion

Area of Science:

• Cell Biology
• Biochemistry
• Endocrinology

Background:

• Insulin secretion by pancreatic beta-cells regulates blood glucose levels.
• Epidermal growth factor (EGF) was previously shown to stimulate insulin secretion by activating phospholipase D2 (PLD2).
• The precise mechanism linking PLD2 activation to insulin secretion remained unclear.

Purpose of the Study:

• To elucidate the mechanism by which PLD2 activation mediates EGF-dependent insulin secretion.
• To investigate the role of cyclin-dependent kinase 5 (Cdk5) in the regulation of PLD2 activity and insulin secretion.

Main Methods:

• Utilized Cdk5 inhibitors (roscovitine) and dominant-negative Cdk5 to assess their impact on EGF-stimulated PLD2 activation and insulin secretion.
• Measured Cdk5 activity and PLD2 phosphorylation in response to EGF stimulation in rat insulinoma RINm5F cells.
• Performed in vitro and in-cell phosphorylation assays to confirm Cdk5-mediated PLD2 phosphorylation.
• Identified the specific phosphorylation site (Ser134) on PLD2 and used a site-directed mutant (PLD2-S134A) to evaluate its functional significance.

Main Results:

• Inhibition of Cdk5 activity blocked EGF-dependent PLD2 activation and subsequent insulin secretion.
• EGF stimulation increased Cdk5 activity, leading to PLD2 phosphorylation at Ser134.
• The PLD2-S134A mutant failed to undergo EGF-dependent phosphorylation and activation by Cdk5, and it could not mediate EGF-induced insulin secretion.

Conclusions:

• Phosphorylation of PLD2 by Cdk5 at Ser134 is a critical step in the signaling pathway of EGF-dependent insulin secretion.
• PLD2 is identified as a novel substrate of Cdk5.
• This study reveals a new regulatory mechanism for insulin secretion involving the Cdk5-PLD2 axis.